2Singal,Mehta J,Desikan R,et al.Antitunmor activity of thalidomide in refractory multiple myeloma.Nengl J Med,1999;341:1565.
3Rajkumar S V,Kyle R A.Angiogenesis in multiple myeloma.Semin Oncol, 2001;28:560.
4Kneller A,Raanani P.Hardan l,et al.Therapy with thalidomide in refractory multiple myeloma patientsthe revival of an old drug.Br J Haematol,2000;108:391.
5Barlogie B,Zangari M,Spencer T,et al.Thalidomide in the management of multiple myeloma.Semin Hematol.2001,38:250.
二级参考文献10
1Kneller A,Raanani P,Hardan A,et al. British Journal of Haematology . 2000
2Julisson G,Cetsing F,Turesson I,et al. British Journal of Haematology . 2000
3Jacobsen JM,Greenspan JS,Spritzler J,et al. The New England Journal of Medicine . 1997
4Vogelsang GB,Farmer ER,Hess AD,et al. The New England Journal of Medicine . 1992
5Vacca A,Ribatti D,Roncali L,et al. British Journal of Haematology . 1994
6Vacca A,Ribatti D,Presta M,et al. Blood . 1999
7Kenyon BM,Browne F,D’Mato RJ,et al. Experimental Eye Research . 1997
8D’Mato RJ,Loughan MS,Flynn E,et al. Proceedings of the National Academy of Sciences of the United States of America . 1994
